Healing & recovery · Tissue repair and cardiovascular protection
TB-500
Tβ4 fragment, T-beta-4, Ac-SDKP
A synthetic fragment of thymosin beta-4 (often residues 17–23), sold separately from the full-length protein that is actually in wound-healing and cardiac trials. TB-500 is a research chemical with no formal human safety file.
- Healing
- Angiogenesis
- Anti-inflammatory
- Wound healing
- Catalog fill
- 10 mg
- Typical water
- 2 mL
- Route
- Subcutaneous
- Cycle
- 4-week load, 4–6 week maintenance, then stop and reassess.
- Approval
- Research chemical only. Full-length thymosin beta-4 is in trials; the TB-500 fragment is not.
- Status
- Research chemical. WADA banned.
- Evidence
- Full-length Tβ4 has trials. The sold fragment has none.
- Research score
- 60 / 100
Mechanism
G-actin sequestration and cell migration, plus VEGF/bFGF. The Ac-SDKP fragment is the piece tied to TGF-β and fibrosis in cardiac models.
Safety file
Full-length Tβ4 looks safe in trials. TB-500’s human safety is unknown. Theoretical cancer risk. WADA prohibited.
- Joint pain
- Headache
- Fatigue
- Temporary local hair growth
Reconstitution
2 mL bacteriostatic water into a 10 mg vial gives 5 mg/mL. A 2 mg draw is 40 units on a U-100 syringe.
Research amounts
Twice weekly for 4 weeks (loading), then once weekly.
| Step | Amount | Frequency | Notes |
|---|---|---|---|
| Loading | 2.0–2.5 mg | Twice weekly | 40–50 units from a 2 mL reconstitution |
| Maintenance | 2.0 mg | Once weekly | 40 units |
Storage
- Lyophilized
- −20 °C freezer preferred; a refrigerator is also acceptable. Do not open a cold vial — wait 15–30 minutes so it does not sweat. Avoid freeze–thaw cycling.
- After water
- 2–8 °C, dark, up to 45 days when mixed with bacteriostatic water. Mixed vials stay in their box. Sterile water (no preservative) is single-use.
Worksheet notes
- Amounts are milligrams, not micrograms — a 2 mg draw is eight times a 250 mcg BPC-157 draw.
- Often paired with BPC-157 rather than run alone. See Wolverine Stack if both are in one vial.
- Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
- Amounts on this sheet are reconstitution math for the vial, not a recommendation.
Full protocol
Titration, schedule, and handling
The complete protocol for TB-500. Where it differs from the worksheet amounts above, the worksheet reflects the NovaEvum vial.
Reconstitution
| Vial | 2 mL water | 3 mL water |
|---|---|---|
| 10 mg | 5 mg/mL | 3.33 mg/mL |
- Use bacteriostatic water as the diluent.
- Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
- Swirl gently to mix, then leave it to dissolve. Do not shake.
- Give it a few minutes. The finished solution should be clear and colourless.
Protocol
Route: Subcutaneous
Standard protocol (subcutaneous)
- Loading: 2 mg to 2.5 mg twice weekly (spaced 3 to 4 days apart, e.g. Monday and Thursday) for 4 to 6 weeks
- Maintenance: 2 mg once weekly after the loading phase
Where it goes
- TB-500 works systemically, so the injection site does not need to be near the injury
- Rotate sites
- Often run as the partner to BPC-157 in a healing stack
Dosing detail
- Loading: about 2 to 2.5 mg twice weekly for 4 to 6 weeks.
- Maintenance: about 2 mg once weekly thereafter.
- Long half-life, so twice-weekly dosing is fine; site does not matter since it acts systemically.
- TB-500 is on the WADA prohibited list and is banned in competitive sport.
Duration
- Load for 4 to 6 weeks, then weekly maintenance. Common overall cycle is 8 to 12 weeks on, then a break.
Notes
- The common partner to BPC-157 for recovery stacks.
- Well tolerated by most.
- Rotate injection sites.
Storage and handling
- Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
- Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 90 days.
- Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
- If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.